Emphasizing Preventer Use and Risks of Over-Reliance on Relievers

Asthma inhalers are essential for managing asthma, a prevalent respiratory condition. Medical professionals have expressed concerns regarding the improper use of blue inhalers by some patients. These inhalers, also known as reliever inhalers, deliver a short-acting bronchodilator to quickly open airways and alleviate symptoms like chest tightness, wheezing, coughing, and breathing difficulties.

The Medicines and Healthcare products Regulatory Agency (MHRA) is worried about the overuse of blue inhalers. They have reminded asthma sufferers about the importance of regularly using their prescribed preventer (anti-inflammatory) inhaler and avoiding sole reliance on the blue inhaler.

Dr. Alison Cave, the MHRA’s chief safety officer, emphasized that patient safety is paramount. She highlighted the importance of using preventer inhalers as prescribed, even when asthma seems controlled. Blue inhalers are crucial for treating symptoms during an asthma attack but should not be the only treatment. Patients who find themselves needing their blue inhaler more than twice a week are advised to consult a healthcare professional. Over-reliance on blue inhalers can worsen symptoms and increase the risk of asthma attacks.

The MHRA also stated that patients prescribed a blue inhaler for asthma attacks should also receive a preventer inhaler for daily use. Research suggests that a significant number of asthma sufferers may be at risk of life-threatening attacks due to relying solely on reliever inhalers. Dr. Cave reiterated that preventer inhalers should be taken as prescribed, even when symptoms are under control. If symptoms worsen or are not relieved by the blue inhaler, patients should seek immediate medical attention. Any suspected side effects should be reported through the Yellow Card scheme.